Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity

Published:2009-02-13 Issue:2 Volume:4 Page:219-224
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Feng Xiao-Qing,Liang Yong-Hong,Zeng Zhao-Sen,Chen Fen-Er,Balzarini Jan,Pannecouque Christophe,De Clercq Erik

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.200800334/fullpdf

Reference29 articles.

1. Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues

2. Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases

3. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors

4. From 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to Etravirine (TMC125): Fifteen Years of Research on Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

5. The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the anti-HIV-1 activity and solubility of poorly water-soluble DAPYs by heteroaromatic replacement strategy: From naphthalene-DAPYs to quinoline-DAPYs;Bioorganic Chemistry;2023-11

2. Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy;Journal of Medicinal Chemistry;2023-03-30

3. Fluorine-containing drugs approved by the FDA in 2021;Chinese Chemical Letters;2023-01

4. Diarylpyrimidines and related analogs as antiviral agents;Privileged Scaffolds in Drug Discovery;2023

5. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel;European Journal of Medicinal Chemistry;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3